Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had their first-ever stroke caused by a blocked artery on the left side of the brain, confirmed by an MRI scan
- People who are at least 3 months past the date their stroke occurred
- People who have a type of language difficulty called non-fluent aphasia, confirmed by a specific language test, with communication challenges ranging from mild to significant, particular trouble finding and naming words, and relatively preserved understanding of everyday speech
- People who are native Polish speakers
- People who were right-handed before their stroke
- People who are willing and able to sign a consent form to take part in the study
Who may not be able to join:
- People who have a psychiatric or neurological condition in addition to their stroke, such as dementia, depression, or alcohol dependence
- People who have been diagnosed with epilepsy, have shown epilepsy-related changes on a brainwave (EEG) test, or who frequently lose consciousness in ways that might suggest seizures
- People who have previously had any surgical procedure involving the head or brain
- People for whom an MRI scan at 1.5 Tesla strength is not safe — for example, those with certain metal devices in their body such as a heart defibrillator or deep brain stimulation device, or those with claustrophobia
- People who regularly take medications that could affect brain activity or the brain's ability to adapt, such as anti-epileptic drugs, antipsychotics, antidepressants, benzodiazepines, or dopamine-related medications
- People with significant thinking or memory difficulties that would limit their ability to take part in assessments and therapy sessions
- People with serious vision problems that would make it difficult to see tasks displayed on a computer screen during therapy
- People who experience a new neurological event (such as another stroke) or a serious illness (such as COVID-19) during the therapy period that requires treatment to be stopped
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Katarzyna E Polanowska, PhD, Institute of Psychiatry and Neurology, Warsaw, Poland
Phone: +48224582870
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from pre-treatment assessment in the performance on a picture naming task; Change from pre-treatment in the performance on the picture naming task at 3 months post-therapy (follow up assessment); Change from post-treatment in the performance on the picture naming task at 3 months post-therapy; Change from pre-treatment assessment in the performance on a scene description task of three visually presented scenes; Change from pre-treatment in the scene description task at 3 months post-therapy; Change from post-treatment in the scene description task at 3 months post-therapy; Change from p...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.